Le Lézard
Classified in: Health
Subjects: CPN, POL, FVT

Dr. Scott Noren Announces His Candidacy for the 2018 US Senate Election In New York


ITHACA, N.Y., Feb. 13, 2018 /PRNewswire-USNewswire/ -- Dr. Noren, an Oral & Maxillofacial Surgeon from Ithaca, NY, has been a health care provider for nearly two decades and served the US Army for six years until 2003. He grew up in the Chicago area, and through military and educational training has lived in very diverse communities, North and South.  He has a wife and four children, two of which reside at home including one with special needs.

Dr. Noren is focusing especially on health care issues bringing to the table innovative ideas to immediately jumpstart affordability and accessibility options. He has worked on the opioid issue with completely unique ideas to address this nationally and locally. He has been a Teamsters provider for 12+ years and a living wage employer for a decade. "Without affordable health care, living wage jobs in NY and nationwide will not grow." Dr. Noren is an advocate of a single payer health care system with good balances and checks.

Another main area of emphasis of his is job creation through business interest free business loans heavily vetted and other ways that allow startups to prosper. He has written a proposal to cap student loan interest at 3% and do away with compounding interest during forbearance and deferment periods. Lastly, he is passionate and persistent about true campaign finance reform.  According to Dr. Noren, "Senators and Representatives should not be on a Committee and receive any donations from sectors they oversee on that Committee."  Dr. Noren said that "although it takes money to campaign, millions of dollars are wasted yearly on campaigns that could be used to stimulate job growth here domestically."

For more information see Dr. Noren's Senate web site at:
http://www.norenforsenate.com

CONTACT: The Office of Dr. Noren for US Senate, at
[email protected]  

SOURCE Dr. Scott Noren For US Senate


These press releases may also interest you

at 04:28
GymNation, the homegrown UAE fitness brand, has today announced that due to unprecedented growth, it is reaching capacity across its 12 UAE gym locations and diversifying into a new market, brewing up a storm with the launch of its first-ever branded...

at 04:00
Cancer spreads from its primary tumor to other parts of the body via blood or the lymphatic system in a process termed 'metastasis'. This usually represents an advanced stage in the disease's progression and tends to be fatal. Therefore, preventing...

at 03:30
Vicore Pharma Holding (STO:VICO)Sessions at ATS to include an oral late-breaking presentation of the final results from the Phase 2a AIR trial of buloxibutid (C21) in IPFAdditional presentations include preclinical and translational data reflecting...

at 03:13
Orexo's Annual and Sustainability Report for 2023 has been published and can be downloaded at, www.orexo.com. The Swedish version of the Report is also available on the company's website in European Single Electronic Format (ESEF). A PDF version is...

at 03:05
Surge has just closed its second round of funding, raising ?7.5 million. The round was led by Eurazeo with the participation of Kima, Teampact, and MH Innov', as well as the support of historical funds Boutique Venture, HCVC, and 50 Partners Santé....

at 03:00
CSL Vifor is pleased that its partner Akebia Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Vafseo (vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD) in adults who...



News published on and distributed by: